Auditors say the IRS's flawed collecting process is bringing only three-quarters or so of the Obamacare-related revenue originally expected.» Read More
Glaxo's problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center.
A poll of doctors finds huge skepticism that Obamacare insurance exchanges will open by fall deadline, and mostly don't know how new health law will affect practices.
GlaxoSmithKline CEO Andrew Witty will detail this week what action the drugmaker is taking in response to allegations of bribery against it in China, sources said.
A study of hospitals found a big disparity between official charges for hip- and knee-replacement surgeries, and that high-volume facilities are often the best choice.
Intuitive Surgical shares fell more than 11 percent after the company slashed its 2013 sales forecast due to disappointing demand for its da Vinci surgical robots and procedures.
President Barack Obama highlighted cost savings delivered by his health-care reform law, arguing that extra dollars in middle-class pockets trumps Republican opponents.
There's a "growing sense of commonality" among the White House, union leaders, and Republicans that the health-care law is not ready, House Majority Leader Eric Cantor told CNBC.
Makers of electronic cigarettes are enjoying a booming market as they keep an eye on the Food and Drug Administration, which is expected to release proposed regulations this fall.
President Obama is set to boast Thursday that Obamacare is giving rebates to 8.5 million Americans this summer and lead to $3.4 billion in reduced insurance premiums.
Heavy patients seeking medical attention are facing an added challenge: they may be too heavy for air ambulances, and the air medical transport industry is rushing to adapt.
China is barring a GlaxoSmithKline executive from leaving the country amid a widening $490 bribery scandal ensaring the drug giant.
UnitedHealth reported quarterly earnings that surpassed analysts' expectations on Thursday.
New data shows employers might be less likely to hire over the next year thanks to Obamacare. But supporters say the law provides quality insurance independent from employers.
China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.
Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.
Less than 90 days before Obamacare's government-run health exchanges are due to open up shop, Web insurers are still being locked out—a lag that could depress enrollment and jack up insurance rates.
Two breast-feeding-related companies are teaming up to help insurers comply with the new Obamacare rule entitling moms to free breast pumps and breast-feeding services.
Doctors in India work to calm the convulsions and keep the children hydrated, but then have to watch helplessly as their young patients die. The New York Times reports.
Johnson & Johnson reported higher-than-expected earnings as strong sales of prescription drugs and medical devices more than offset anemic growth of its consumer products.
In a recent study, fish oil proved dangerous for men who have high levels of the compounds because it raises the risk of prostate cancer.
Get the best of CNBC in your inbox